Copyright©2010 Antony Williams
The first circular for the 16th RSC-SCI Medicinal Chemistry Symposium, 11-14 September 2011, Churchill College, Cambridge, UK is now available here.
Strategies to success – H-PGDS inhibitors for the treatment of inﬂamatory disorders, Sukanthini Thurauratnam, Sanoﬁ -Aventis
Discovery on next generation glucokinase activators, Mike Waring, AstraZeneca
Inhalation by design, Paul Glosson, Pﬁzer
Bromodomains a new class of epigenetic targets for small molecule drug discovery, Jason Witherington, GSK
GPCR Structure based drug design using stabilised receptors(StaRs), Miles Congreve, Heptares
GS-9350: a novel pharmacoenhancer, Lianhong Xu, Gilead Sciences